NMRA vs OVID

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

NMRA

31.0
AI Score
VS
OVID Wins

OVID

39.2
AI Score

Investment Advisor Scores

NMRA

31score
Recommendation
SELL

OVID

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NMRA OVID Winner
Net Income -96.54M -17.40M OVID
Operating Income -95.05M -42.44M OVID
ROE -216.9% -13.3% OVID
ROA -77.1% -11.5% OVID
Total Assets 125.25M 150.93M OVID
Cash 116.83M 13.15M NMRA
Current Ratio 4.50 8.97 OVID

Relative Price Performance (Last 90 Days)

NMRA 1M: +6.7% · 3M: -72.7% OVID 1M: +16.2% · 3M: +6.9%

Current Technical Phase

NMRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -40.9%), weak momentum, RSI 44

RSI (14): 44.3 · Price: $0.47

OVID

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.4 · Price: $2.80

Fundamentals Snapshot

Metric NMRA OVID
Market Cap — —
Forward P/E -0.7 -7.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.9%
Gross Margin — 1.0%
Operating Margin 0.0% -21.0%
EPS -1.20 -0.22
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, OVID is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.